Cited by

• Emerging hurdles in stem cell therapy for peripheral vascular disease.

  Aranguren XL, Verfaillie CM, Luttun A. Aranguren XL, et al. J Mol Med (Berl). 2009 Jan;87(1):3-16. doi: 10.1007/s00109-008-0394-3. Epub 2008 Aug 19. J Mol Med (Berl). 2009. PMID: 18712330 Review.
• Aged Human Multipotent Mesenchymal Stromal Cells Can Be Rejuvenated by Neuron-Derived Neurotrophic Factor and Improve Heart Function After Injury.

  Song HF, He S, Li SH, Yin WJ, Wu J, Guo J, Shao ZB, Zhai XY, Gong H, Lu L, Wei F, Weisel RD, Xie J, Li RK. Song HF, et al. JACC Basic Transl Sci. 2017 Nov 29;2(6):702-716. doi: 10.1016/j.jacbts.2017.07.014. eCollection 2017 Dec. JACC Basic Transl Sci. 2017. PMID: 30062183 Free PMC article.
• Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?

  Dimmeler S, Zeiher AM. Dimmeler S, et al. J Mol Med (Berl). 2004 Oct;82(10):671-7. doi: 10.1007/s00109-004-0580-x. J Mol Med (Berl). 2004. PMID: 15322703 Review.
• Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients.

  Wang W, Li W, Ou L, Flick E, Mark P, Nesselmann C, Lux CA, Gatzen HH, Kaminski A, Liebold A, Lützow K, Lendlein A, Li RK, Steinhoff G, Ma N. Wang W, et al. J Cell Mol Med. 2011 Sep;15(9):1989-98. doi: 10.1111/j.1582-4934.2010.01130.x. Epub 2010 Jul 13. J Cell Mol Med. 2011. PMID: 20629995 Free PMC article.
• Aging and endothelial progenitor cell telomere length in healthy men.

  Kushner EJ, Van Guilder GP, Maceneaney OJ, Cech JN, Stauffer BL, DeSouza CA. Kushner EJ, et al. Clin Chem Lab Med. 2009;47(1):47-50. doi: 10.1515/CCLM.2009.016. Clin Chem Lab Med. 2009. PMID: 19055473 Free PMC article.